{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:30:33Z","timestamp":1782390633242,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.eplepsyres.2008.04.010","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T06:23:46Z","timestamp":1212042226000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice"],"prefix":"10.1016","volume":"81","author":[{"given":"Arash","family":"Bahremand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ebrahimi","family":"Nasrabady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2008.04.010_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.105.100354","article-title":"Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus","volume":"317","author":"Blair","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)37876-0","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"Bonhaus","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0014-2999(99)00349-0","article-title":"Dual intracellular signaling pathways mediated by the human cannabinoi CB1 receptor","volume":"374","author":"Calandra","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00421539","article-title":"Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin","volume":"37","author":"Chesher","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1992.tb25954.x","article-title":"Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain","volume":"654","author":"Childers","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib6","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.92.23.10540","article-title":"Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance\/dependence during chronic co-treatment","volume":"92","author":"Crain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0165-6147(98)01241-3","article-title":"Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions","volume":"19","author":"Crain","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3959(99)00223-7","article-title":"Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance\/dependence liability","volume":"84","author":"Crain","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0885-3924(03)00139-8","article-title":"Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone","volume":"25","author":"Cruciani","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2003.08.015","article-title":"Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats","volume":"123","author":"Eells","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004691-199204010-00007","article-title":"Subcortical structures and pathways involved in convulsive seizure generation","volume":"9","author":"Gale","year":"1992","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuropharm.2007.08.005","article-title":"Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice.","volume":"53","author":"Gholizadeh","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib17","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet restricted mice","volume":"392","author":"Hao","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2004.08.029","article-title":"Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures","volume":"129","author":"Honar","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib21","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/0006-2952(89)90628-X","article-title":"Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies","volume":"38","author":"Howlett","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib23","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI113768","article-title":"Potentiation of pentazocine analgesia by low-dose naloxone","volume":"82","author":"Levine","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2001.00002.x","article-title":"Animal models used in the screening of antiepileptic drugs","volume":"42","author":"Kupferberg","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action","volume":"27","author":"Leach","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.12.013","article-title":"Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists","volume":"560","author":"McNaull","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for a new antiepileptic drug? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib30","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","article-title":"Functional interaction between opioid and cannabinoid receptors in drug self-administration","volume":"21","author":"Navarro","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008877-200512000-00001","article-title":"Ultra-low dose naltrexone enhances cannabinoid-induced antinociception","volume":"16","author":"Paquette","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib32","series-title":"Cannabinoid Receptors","first-page":"69","article-title":"Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors","author":"Pertwee","year":"1995"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by \u03bc-opioid receptor agonists","volume":"147","author":"Saidak","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/ebeh.2001.0193","article-title":"Overview of the current animal models for human seizure and epileptic disorders","volume":"2","author":"Sarkisian","year":"2001","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2007.04.005","article-title":"Role of ATP-sensitive potassium channels in the effect of morphine on pentylenetetrazole-induced seizure threshold in mice","volume":"75","author":"Shafaroodi","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0006-8993(94)91028-6","article-title":"Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance\/dependence","volume":"636","author":"Shen","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(97)00197-2","article-title":"Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuates tolerance\/dependence in mice","volume":"757","author":"Shen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib41","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib42","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib43","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.06.003","article-title":"Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and G betagamma signaling","volume":"135","author":"Wang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2008.04.010_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121108001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121108001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:19:59Z","timestamp":1760275199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121108001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0920121108001150"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.04.010","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}